Hotchkis & Wiley Capital Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.74M Buy
235,015
+54,880
+30% +$783K 0.01% 442
2026
Q1
$3.02M Sell
180,135
-370,980
-67% -$6.64M 0.01% 434
2025
Q4
$8.83M Sell
551,115
-8,510
-2% -$127K 0.03% 277
2025
Q3
$6.92M Buy
559,625
+101,755
+22% +$1.19M 0.02% 319
2025
Q2
$5.27M Buy
457,870
+57,080
+14% +$677K 0.02% 389
2025
Q1
$6.01M Buy
+400,790
New +$6.71M 0.02% 340
2024
Q3
Sell
-358,270
Closed -$7.27M 492
2024
Q2
$7.27M Buy
358,270
+1,590
+0.4% +$28.1K 0.03% 310
2024
Q1
$6.09M Buy
+356,680
New +$5.61M 0.02% 351
2022
Q3
Sell
-170,860
Closed -$3.38M 521
2022
Q2
$3.38M Sell
170,860
-18,970
-10% -$504K 0.01% 397
2022
Q1
$6M Sell
189,830
-1,370
-0.7% -$38.4K 0.02% 314
2021
Q4
$4.27M Buy
191,200
+117,620
+160% +$3.07M 0.01% 378
2021
Q3
$2.04M Sell
73,580
-16,780
-19% -$511K 0.01% 460
2021
Q2
$3.52M Sell
90,360
-1,260
-1% -$45.2K 0.01% 397
2021
Q1
$2.64M Buy
91,620
+22,830
+33% +$780K 0.01% 401
2020
Q4
$1.82M Buy
+68,790
New +$1.4M 0.01% 417

Other funds holding CLB

Hotchkis & Wiley Capital Management's CLB Position: Q2 2026 in Review

Hotchkis & Wiley Capital Management increased its Core Laboratories (CLB) stake by 30% in Q2 2026, buying an estimated $783K and bringing the position to 235,015 shares worth $2.74M. The position accounts for 0.01% of the portfolio, ranked #442.

Hotchkis & Wiley Capital Management first reported a position in CLB in Q4 2020 and has held it in 15 quarters since. The position peaked at $8.83M in Q4 2025. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Hotchkis & Wiley Capital Management held 235,015 shares of Core Laboratories worth $2.74M as of Q2 2026.
  • Hotchkis & Wiley Capital Management bought 54,880 Core Laboratories shares in Q2 2026, an estimated $783K.
  • Core Laboratories made up 0.01% of Hotchkis & Wiley Capital Management's portfolio in Q2 2026, its #442 holding.
  • Hotchkis & Wiley Capital Management first reported a position in Core Laboratories in Q4 2020 and has held it in 15 quarters since.
  • Hotchkis & Wiley Capital Management's Core Laboratories position peaked at $8.83M in Q4 2025.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Hotchkis & Wiley Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.